CTRI Number |
CTRI/2019/04/018743 [Registered on: 24/04/2019] Trial Registered Prospectively |
Last Modified On: |
18/04/2019 |
Post Graduate Thesis |
No |
Type of Trial |
Observational |
Type of Study
|
Follow Up Study |
Study Design |
Single Arm Study |
Public Title of Study
|
The value of flow measurements in brain Aneurysms |
Scientific Title of Study
|
Multicenter observational cohort study to evaluate
Cerebral AneurysmFlow Results in Occlusion (CARO) |
Trial Acronym |
CARO |
Secondary IDs if Any
|
Secondary ID |
Identifier |
NCT03663257 |
ClinicalTrials.gov |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Santhosh Joseph |
Designation |
PI CARO Study Chennai |
Affiliation |
Professor&Head Dept. of Neuro-Radiology and Div. of Interventional Radiology |
Address |
Sri Ramachandra Medical Center
Department of Neuro-Radiology
No.1 Ramachandra Nagar
Porur
Chennai
Tamil Nadu
India 600 116
Chennai TAMIL NADU 600116 India |
Phone |
|
Fax |
|
Email |
santhoshjo@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Santhosh Joseph |
Designation |
PI CARO Study Chennai |
Affiliation |
Professor&Head Dept. of Neuro-Radiology and Div. of Interventional Radiology |
Address |
Sri Ramachandra Medical Center
Department of Neuro-Radiology
No.1 Ramachandra Nagar
Porur
Chennai
Tamil Nadu
India 600 116
Chennai TAMIL NADU 600116 India |
Phone |
|
Fax |
|
Email |
santhoshjo@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Santhosh Joseph |
Designation |
PI CARO Study Chennai |
Affiliation |
Professor&Head Dept. of Neuro-Radiology and Div. of Interventional Radiology |
Address |
Sri Ramachandra Medical Center
Department of Neuro-Radiology
No.1 Ramachandra Nagar
Porur
Chennai
Tamil Nadu
India 600 116
Chennai TAMIL NADU 600116 India |
Phone |
|
Fax |
|
Email |
santhoshjo@gmail.com |
|
Source of Monetary or Material Support
|
Philips
Veenpluis 6
5684PC Best
The Netherlands |
|
Primary Sponsor
|
Name |
Philips |
Address |
Veenpluis 6
5684PC
Best
The Netherlands |
Type of Sponsor |
Other [Medical Device Company] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
Argentina Canada India United States of America |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Santhosh Joseph |
Sri Ramachandra Medical College and Research Institute |
Sri Ramachandra Medical Center
Department of Neuro-Radiology
No.1 Ramachandra Nagar
Porur
Chennai
Tamil Nadu
India 600 116 Chennai TAMIL NADU |
044-45928653
santhoshjo@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Sri Ramachandra Medical College and Research Inistitute |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: G938||Other specified disorders of brain, |
|
Intervention / Comparator Agent
|
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
99.00 Year(s) |
Gender |
Male |
Details |
1. Subject with unruptured, 5rnm saccular aneurysm(s) located in the anterior intracranial
circulation and suitable for an endovascular treatment with a Flow Diverter Stent
2. Subject is 18 years of age or older, or of legal age to give informed consent per state or national law
3. Subject is available for clinical follow-ups |
|
ExclusionCriteria |
Details |
1. Non-saccular brain aneurysm(s) (i.e., dissecting, fusiform, atherosclerotic, mycotic, bifurcational)
2. Prior aneurysm treatment with either endovascular (stenting, coiling) or surgical (clipping) techniques
3. Endovascular treatment assisted with coils or intracranial stents
4. Significant or severe allergy to intra-arterial contrast medium uncontrolled by pre-procedure medications
5. Severe kidney disease (e-GFR < 60)
6. Subjects not willing (or able) to attend post FDS insertion standard-of-care follow up clinic visits requiring DSA, head MRI or CTA imaging
7. Subject participates in a potentially confounding drug or device trial during the course of the study.
8. Subject meets an exclusion criteria according to national law (e.g. age, pregnant woman, breastfeeding woman) |
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
Full aneurysm occlusion 12
months after flow diverter placement |
12 months after flow diverter placement |
|
Secondary Outcome
|
Outcome |
TimePoints |
Full aneurysm occlusion 6
months after flow diverter placement |
6 months after flow diverter placement |
|
Target Sample Size
|
Total Sample Size="120" Sample Size from India="25"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
01/05/2019 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
15/10/2018 |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Open to Recruitment |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
NIL |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
This is a prospectively planned, single arm, observational, multicenter cohort study to assess the prognostic value of the MAFA ratio using AneurysmFlow (i.e. an approved software tool from Philips intended to provide relevant information on the blood flow in a cerebral aneurysm and its parent artery based on angiography 2D flow measurement) for predicting full aneurysm occlusion 12 months after flow diverter placement. |